{"transactions":[{"id":1435393,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":88357,"kind":"person","name":"Grant Angus","position":1,"cik":"0001988830","reported_name":"Grant Angus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Restricted Share Units","published_at":"2024-08-13T20:06:50.000Z","date":"2024-08-09","kind":"exercise","planned":true,"acquired":false,"shares":12913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on August 9 ,2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on August 9 ,2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38739,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12913},"source":{"system":"sec-edgar","filing":"0000950170-24-096182","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024096182/ownership.xml","form_type":"4"}},{"id":1435392,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":88357,"kind":"person","name":"Grant Angus","position":1,"cik":"0001988830","reported_name":"Grant Angus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2024-08-13T20:06:50.000Z","date":"2024-08-09","kind":"sale","planned":true,"acquired":false,"shares":4065,"price":17.28,"value":70243.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":8848,"source":{"system":"sec-edgar","filing":"0000950170-24-096182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024096182/ownership.xml","form_type":"4"}},{"id":1435391,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":88357,"kind":"person","name":"Grant Angus","position":1,"cik":"0001988830","reported_name":"Grant Angus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2024-08-13T20:06:50.000Z","date":"2024-08-09","kind":"exercise","planned":true,"acquired":true,"shares":12913,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12913,"source":{"system":"sec-edgar","filing":"0000950170-24-096182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024096182/ownership.xml","form_type":"4"}},{"id":1600202,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":88357,"kind":"person","name":"Grant Angus","position":1,"cik":"0001988830","reported_name":"Grant Angus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:30:16.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":52083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2024, with 13,020 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 13,023 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2024, with 13,020 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 13,023 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":52083,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52083},"source":{"system":"sec-edgar","filing":"0000950170-24-026019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026019/ownership.xml","form_type":"4"}},{"id":1811310,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":88357,"kind":"person","name":"Grant Angus","position":1,"cik":"0001988830","reported_name":"Grant Angus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Restricted Share Units","published_at":"2023-08-10T20:05:17.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":51652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 9, 2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 9, 2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":51652,"derivative":{"underlying":"Ordinary Shares","underlying_shares":51652},"source":{"system":"sec-edgar","filing":"0001209191-23-045292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123045292/doc4.xml","form_type":"4"}}]}